Japanese biotech firm uses tiny worms in test for pancreatic cancer
TOKYO — A Japanese biotech firm says it has developed the world's first early screening test for pancreatic cancer, using the powerful noses of tiny worms. Hirotsu Bio Science this month launched its N-Nose plus Pancreas test, marketing directly to consumers in Japan and with aims to bring the test to the US by 2023. Users send a urine sample...